-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$22.00138.35% Upside
89bio, Inc. Frequently Asked Questions
-
What analysts cover 89bio, Inc.?
89bio, Inc. has been rated by research analysts at RBC Capital, UBS, H.C. Wainwright in the past 90 days.